Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - FENNEC PHARMACEUTICALS INC. | tm21107d1_10k.htm |
| EX-99.1 - EXHIBIT 99.1 - FENNEC PHARMACEUTICALS INC. | tm21107d1_ex99-1.htm |
| EX-32.1 - EXHIBIT 32.1 - FENNEC PHARMACEUTICALS INC. | tm21107d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - FENNEC PHARMACEUTICALS INC. | tm21107d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - FENNEC PHARMACEUTICALS INC. | tm21107d1_ex31-1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (file nos. 333-221091 and 333-232353) and S-3 (file nos. 333-219884 and 333-249775) of Fennec Pharmaceuticals Inc. (the “Company”) of our report dated March 30, 2021 relating to the consolidated financial statements as of December 31, 2020, which appear in the Annual Report on Form 10-K for the year ended December 31, 2020.
| /s/ HASKELL & WHITE LLP | ||
| HASKELL & WHITE LLP |
Irvine, California
March 30, 2021